Echosens stock
WebOct 27, 2011 · Echosens products are widely available in most global markets and the company is actively pursuing the necessary FDA approvals to homologate its devices for sale in the United States. WebEchosens is a high-tech company specializing in non-invasive diagnostic products and services for hepatology. Use the CB Insights Platform to explore Echosens's full profile. ... Sonic Incytes Medical, Terns, Viking Therapeutics), stock and/or options (self-managed) (Akero Therapeutics, ChronWell, Cirius Therapeutics, Galectin Therapeutics ...
Echosens stock
Did you know?
WebEchosens 13,277 followers on LinkedIn. Empowering medical professionals to assess, diagnose and manage chronic liver diseases. Because Liver Health Matters. A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. …
WebJun 21, 2024 · PARIS & WALTHAM, Mass., June 21, 2024--Echosens Presents Symposium & Democenter at EASL International Liver Congress 2024. ... The U.S. … WebAug 27, 2024 · Echosens, a high-technology company offering the FibroScan family of products, today announces the appointment of Jon Gingrich as CEO, Echosens North …
WebApr 18, 2024 · To further support clinicians in their fight against such diseases, Echosens and GE Healthcare have joined forces to offer a new integrated system, the LOGIQ™ S8 XDclear™ 2.0 ultrasound system ... WebMar 9, 2024 · 4 Fundings. Echosens's latest funding round was a Secondary Market for on March 9, 2024. Date. Round. Amount. Investors. Valuation. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. Revenue.
WebNov 18, 2024 · Lille (France), Cambridge (Massachusetts, États-Unis), le 18 novembre 2024 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique de phase avancée engagée dans l’amélioration de la vie des patients atteints de sévères maladies chroniques du foie, annonce aujourd’hui que l’utilité de sa technologie NIS4® a été reconnue dans la …
WebApr 29, 2015 · Paris – 29th April 2015: ECHOSENS, leader in both in vivo and in vitro hepatic diagnosis and specialized in the design, production and distribution of medical … stress redhatWebJun 21, 2024 · PARIS & WALTHAM, Mass., June 21, 2024--Echosens Presents Symposium & Democenter at EASL International Liver Congress 2024. ... The U.S. stock market resumes its normal trading hours on Monday ... stress reasonsWebJul 28, 2024 · PARIS & WALTHAM, Mass., July 28, 2024--(BUSINESS WIRE)--Echosens, a high-technology company offering liver diagnostic solutions, establishes its support of World Hepatitis Day (WHD), July 28 by ... stress redness of faceWebEchosens’ FibroScan devices have introduced a breakthrough approach to the diagnosis of hepatitis by providing a non-invasive, easier to use and cost-effective alternative to the biopsy with no risk of complications. … stress reducer elixirWebJun 9, 2024 · Jon Gingrich, CEO, Echosens North America: “Research demonstrates that broad deployment of VCTE devices, like FibroScan, is a financially advantageous solution to address the fatty liver disease ... stress reducer for betta fishWebEchosens is a company that provides patient care in hepatology. It focuses on various types of chronic liver diseases, including diseases caused by a virus, such as HBV and … stress reducing ear plugsWeb女: 国 籍--年龄: 44岁: 最高学历: 硕士研究生: 所属行业: 计算机服务: 职称--专业技术资格--简 介: 冷静：女，中国国籍，1979年出生，研究生学历，曾任中科院深圳先进技术研究院工程中心副主任、法国Echosens亚太区总经理，现任深圳市远致富海投资管理有限公司投资总监。 stress reducing conversation gottman